Document Classification

Section Type: RESULTS

Text: More patients receiving lanreotide than placebo were responders ; this difference was not statistically significant for the intent-to-treat (ITT) population on the basis of diary cards (primary analysis ; 41. 9 % [18 of 43] v 29. 7 % [11 of 37], respectively ; odds ratio, 1. 75 ; 95 % CI, 0. 68 to 4. 49 ; P =. 24) but was statistically significant for the corresponding supportive per protocol analysis (57. 7 % [15 of 26] v 30. 4 % [seven of 23] ; P <. 05) and ITT analysis, on the basis of investigators'assessments (50. 0 % [19 of 38] v 28. 6 % [10 of 35] ; P <. 05).